Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — November 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.4k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • D Offline
    D Offline
    deleted-user
    wrote on sidst redigeret af
    #137

    ? Børsen?

    1 Reply Last reply
    0
    • A Offline
      A Offline
      AaBforever
      wrote on sidst redigeret af
      #138

      Gen­mab over­går for­vent­nin­ger i tred­je kvar­tal/Børsen

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #139

        Link Preview Image
        Siden findes ikke

        favicon

        (borsen.dk)

        1 Reply Last reply
        0
        • Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktør
          wrote on sidst redigeret af
          #140

          Rapporten: https://ir.genmab.com/news-releases/news-release-details/genmab-announces-financial-results-first-nine-months-2020

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #141

            Is this one new? JNJ-70218902
            • Phase 1 study in advanced stage solid tumors ongoing
            • Developed by Janssen under the DuoBody technology collaboration
            / JNJ-70218902 is a bispecific antibody created by Janssen using Genmab's DuoBody technology. It is
            being investigated in a Phase 1 clinical study for the treatment of advanced stage solid tumors.
            Third Quarter 2020 Update
            • September: A Phase 1 study of JNJ-70218902 in patients with advanced solid tumors was
            initiated.

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #142

              it is in trial for Metastatic Castration-Resistant Prostate Cancer https://clinicaltrials.gov/ct2/show/NCT04397276

              1 Reply Last reply
              0
              • G Offline
                G Offline
                GeorgeBest
                wrote on sidst redigeret af
                #143

                Sounds new E L

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #144

                  and PRV-015 (AMG 714)
                  • Antibody targeting IL-15
                  • In clinical development for celiac disease
                  ?

                  1 Reply Last reply
                  0
                  • A Offline
                    A Offline
                    AaBforever
                    wrote on sidst redigeret af
                    #145

                    Biotek...healthcare... ok i dag...tror også nohope er tilfreds..:-D

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #146

                      in august "Provention Bio Announces Initiation of Phase 2b PROACTIVE Study of PRV-015 (anti-IL-15) in Non-responsive Celiac Disease " https://www.prnewswire.com/news-releases/provention-bio-announces-initiation-of-phase-2b-proactive-study-of-prv-015-anti-il-15-in-non-responsive-celiac-disease-301120649.html

                      1 Reply Last reply
                      0
                      • Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktør
                        wrote on sidst redigeret af
                        #147

                        Just a moment...

                        favicon

                        (www.proinvestor.com)

                        1 Reply Last reply
                        0
                        • A Offline
                          A Offline
                          AaBforever
                          wrote on sidst redigeret af
                          #148

                          Men spændende at se hvad der sker de næste timer/
                          dage i US.

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #149

                            PRV-015 in Gluten-free Diet Non-responsive Celiac Disease (PROACTIVE) https://clinicaltrials.gov/ct2/show/NCT04424927?term=PRV-015&draw=2&rank=1

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #150

                              hmmm, the €20mn Curevac investment now worth dkk644mn...

                              1 Reply Last reply
                              0
                              • SolsenS Offline
                                SolsenS Offline
                                Solsen
                                wrote on sidst redigeret af
                                #151

                                Succes hele vejen rundt 😉

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #152

                                  audio isn't great on this call, i hope you can hear it better than
                                  me...

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #153

                                    epco abstract there now - Subcutaneous Epcoritamab Induces Complete Responses with an Encouraging Safety Profile across Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Subtypes https://ashpublications.org/blood/article/136/Supplement 1/45/470017/Subcutaneous-Epcoritamab-Induces-Complete?searchresult=1

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #154

                                      Novel Semi-Mechanistic Model Leveraging Preclinical and Clinical Data to Inform the Recommended Phase 2 Dose (RP2D) Selection for Epcoritamab (DuoBody CD3xCD20) https://ashpublications.org/blood/article/136/Supplement 1/35/472423/Novel-Semi-Mechanistic-Model-Leveraging?searchresult=1

                                      1 Reply Last reply
                                      0
                                      • S Offline
                                        S Offline
                                        Sukkeralf
                                        wrote on sidst redigeret af
                                        #155

                                        https://finance.yahoo.com/news/igm-biosciences-present-first-clinical-142000020.html

                                        1 Reply Last reply
                                        0
                                        • K Offline
                                          K Offline
                                          Klarussen
                                          wrote on sidst redigeret af
                                          #156

                                          Stort tillykke til de vedholdende Genmab aktionærer. Det betaler sig at være langsigtet og undgå panik selvom det af og til kan gøre ondt og klø i salgsknapfingeren
                                          et stykke tid.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger